Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$16.75
-$0.19 (-1.1%)
Closing Price on November 14, 2024

TEVA Articles

October 14, 2016: Here are four stocks trading with relatively heavy volume among 57 equities making new 52-week lows in Friday’s session. On the NYSE, advancers led decliners by just better than...
October 12, 2016: Here are four stocks trading with relatively heavy volume among 52 equities making new 52-week lows in Wednesday’s session. On the NYSE, advancers led decliners by a slim margin...
The September 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks, short interest was mixed.
October 5, 2016: Here are four stocks trading with relatively heavy volume among 25 equities making new 52-week lows in Wednesday’s session. On the NYSE advancers led decliners by nearly 2 to 1 and...
October 3, 2016: Here are four stocks trading with relatively heavy volume among 29 equities making new 52-week lows in Monday’s session. Wells Fargo & Co. (NYSE: WFC) lost about 1.6% Monday to...
September 30, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in Friday’s session. Cognizant Technology Solutions Corp. (NASDAQ: CTSH)...
September 29, 2016: Here are four stocks trading with relatively heavy volume among 42 equities making new 52-week lows in Thursday’s session. NYSE decliners led advancers by 3 to 1 and Nasdaq...
The September 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has increased.
We liked the list of Buy-rated stocks in a recent Jefferies research piece, as they are all good stealth plays. That is, they are top companies, under the radar, that have a big impact in their...
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
The top analyst upgrades, downgrades and initiations seen on Friday morning include Carnival, Ciena, MercadoLibre, Spark Therapeutics, Smith & Wesson, Teva Pharmaceutical and Verifone.
The top analyst upgrades, downgrades and initiations seen on Thursday morning include DDR, HP, L-3 Communications, Salesforce.com, Teva Pharmaceutical and Twilio.
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.